SEC Form 4 · accession 0001209191-17-063199
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shaun D McMeans
Officer — VP, Finance & Admin. & CFO
Period of report
Dec 1, 2017
Accepted (ET)
Dec 1, 2017 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 1, 2017 | S | 945 | $2.1081 | D | 42,303 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on September 15, 2017.
- F2The weighted average sale price for the transaction reported was $2.1081, and the range of prices were between $2.10 and $2.15. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.